United States · FDA National Drug Code directory
Metronidazole
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 46708-435_73035cba-781b-4d60-80bb-8f8ff273a0a1
- Product NDC
- 46708-435
- Form
- CAPSULE
- Composition / generic term
- metronidazole
- Labeler
- Alembic Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20161209
- Source listing expiry
- 20261231
Source-listed ingredients
- METRONIDAZOLE — 375 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (46708-435-30) · 46708-435-30
- 100 CAPSULE in 1 BOTTLE (46708-435-31) · 46708-435-31
- 50 CAPSULE in 1 BOTTLE (46708-435-50) · 46708-435-50
- 500 CAPSULE in 1 BOTTLE (46708-435-71) · 46708-435-71
- 1000 CAPSULE in 1 BOTTLE (46708-435-91) · 46708-435-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →